These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 14081277)

  • 1. INACTIVATION OF ANTIPLASMIN AND COMPLEMENT C1 IN HUMAN PLASMA RENDERED FIBRINOLYTIC BY SYNTHETIC ORGANIC COMPOUNDS.
    VONKAULLA KN
    Thromb Diath Haemorrh; 1963 Nov; 10():151-63. PubMed ID: 14081277
    [No Abstract]   [Full Text] [Related]  

  • 2. ENHANCEMENT OF FIBRINOLYSIS AND ANTAGONISM OF ANTIPLASMIN BY REVERSIBLE PLASMIN INHIBITORS.
    MAXWELL RE; LEWANDOWSKI V; NICKEL VS
    Life Sci (1962); 1965 Jan; 4():45-51. PubMed ID: 14257064
    [No Abstract]   [Full Text] [Related]  

  • 3. [NEUTRALIZATION OF ANTIPLASMIN IN THE BLOOD DURING PROTECTIVE REACTIONS OF THE PHYSIOLOGIC ANTICOAGULATION SYSTEM].
    KUDRIASHOV BA; ANDREENKO GV; KALISHEVSKAIA TM
    Probl Gematol Pereliv Krovi; 1964 Apr; 9():12-5. PubMed ID: 14195816
    [No Abstract]   [Full Text] [Related]  

  • 4. [ON THE DEFENSIVE REFLEX ANTIPLASMIN SYSTEM IN THE BODY].
    KUDRIASHOV BA; KALISHEVSKAIA TM
    Biull Eksp Biol Med; 1963 Sep; 56():29-33. PubMed ID: 14124776
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasmin-antiplasmin complex as a reservoir of fibrinolytic enzyme.
    AMBRUS CM; MARKUS G
    Am J Physiol; 1960 Sep; 199():491-4. PubMed ID: 13682944
    [No Abstract]   [Full Text] [Related]  

  • 6. AN ACTIVE STEREO-ISOMER (TRANS-FORM) OF AMCHA AND ITS ANTIFIBRINOLYTIC (ANTIPLASMINIC) ACTION IN VITRO AND IN VIVO.
    OKAMOTO S; SATO S; TAKADA Y; OKAMOTO U
    Keio J Med; 1964 Dec; 13():177-85. PubMed ID: 14279228
    [No Abstract]   [Full Text] [Related]  

  • 7. An enzyme-linked immunosorbent assay (ELISA) for the measurement of plasmin-alpha 2-antiplasmin complex in human plasma--application to the detection of in vivo activation of the fibrinolytic system.
    Holvoet P; de Boer A; Verstreken M; Collen D
    Thromb Haemost; 1986 Oct; 56(2):124-7. PubMed ID: 2433784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha 2-plasmin inhibitor-plasmin complexes in synovial fluid.
    Inman RD; Harpel PC
    J Rheumatol; 1986 Jun; 13(3):535-7. PubMed ID: 2942685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACTIVATION OF FIBRINOLYTIC ENZYMES IN BANK BLOOD BY ADDITION OF SYNTHETIC COMPOUNDS. RELATION OF ACTIVITY TO CHEMICAL STRUCTURE.
    VONKAULLA KN
    Bibl Haematol; 1964; 19():174-81. PubMed ID: 14266993
    [No Abstract]   [Full Text] [Related]  

  • 10. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
    Carpenter SL; Mathew P
    Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.
    Singh S; Houng A; Reed GL
    Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN; Kizim AI
    Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyethyl starch enhances fibrinolysis in human plasma by diminishing alpha2-antiplasmin-plasmin interactions.
    Nielsen VG
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):647-56. PubMed ID: 17890952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial purification of bovine antiplasmin (antifibrinolysin).
    COLE ER; DALBY A; MERTZ ET
    Can J Biochem Physiol; 1960 Sep; 38():1021-7. PubMed ID: 13811110
    [No Abstract]   [Full Text] [Related]  

  • 15. Carbon monoxide releasing molecule-2 enhances α2-antiplasmin activity.
    Malayaman SN; Cohen JB; Machovec KA; Bernhardt BE; Arkebauer MR; Nielsen VG
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):345-8. PubMed ID: 21330914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
    Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
    Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [STUDIES ON TRYPSIN INHIBITOR AND ANTIPLASMIN IN HUMAN SERUM. I. ON NORMAL AND ARTERIOSCLEROTIC CASES].
    MATSUDA T
    Nihon Ketsueki Gakkai Zasshi; 1963 Oct; 26():581-9. PubMed ID: 14095688
    [No Abstract]   [Full Text] [Related]  

  • 18. Carbon monoxide and nitric oxide modulate α₂-antiplasmin and plasmin activity: role of heme.
    Arkebauer MR; Kanaparthy SS; Malayaman SN; Vosseller K; Nielsen VG
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):712-9. PubMed ID: 22024794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of the fibrinolytic response on disseminated intravascular coagulation].
    García Frade LJ; García Avello A
    Sangre (Barc); 1993 Jun; 38(3):221-4. PubMed ID: 7692611
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the mechanism of action of synthetic antifibrinolytics. A comparison with the action of derivatives of benzamidine on the fibrinolytic process.
    Landmann H
    Thromb Diath Haemorrh; 1973 May; 29(2):253-75. PubMed ID: 4271586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.